Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A comparative study of infection and mortality in COVID-19 across countries: A scaling analysis

Ranjan Das, Akmal Hossain, Sayak Mandal, Debasmita Pariari, Rohit Kumar Rohj, Swapnil Shukla, Rahul Mahavir Varma, D. D. Sarma
doi: https://doi.org/10.1101/2020.10.13.20212175
Ranjan Das
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akmal Hossain
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sayak Mandal
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debasmita Pariari
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rohit Kumar Rohj
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swapnil Shukla
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rahul Mahavir Varma
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. D. Sarma
1Solid State and Structural Chemistry Unit, Indian Institute of Science, Bengaluru 560012, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sarma@iisc.ac.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Analysing infection and mortality data for COVID-19 as a function of days for 54 countries across all continents, we show that there is a simple scaling behaviour connecting these two quantities for any given nation when the data is segmented over few ranges of dates covering the most rapid spread of the pandemic and the recovery, wherever achieved. This scaling is described by two parameters, one representing a shift along the time axis and the other is a normalisation factor, providing a reliable definition of the mortality rate for each country in a given period. The number of segments for any country required in our analyses turns out to be surprisingly few with as many as 16 out of 54 countries being described by a single segment and no country requiring more than three segments. Estimates of the shift and mortality for these 54 countries in different periods show large spreads ranging over 0-16 days and 0.45-19.96%, respectively. Shift and mortality are found to be inversely correlated. Analyses of number of tests carried out for detecting COVID-19 and the number of infections detected due to such tests suggest that an effective way to increase the shift, and therefore, decrease mortality, is to increase number of tests per infection detected. This points to the need of a dynamic management of testing that should accelerate with the rise of the pandemic; it also suggests a basis for adjusting variations in the testing patterns in different geographical locations within a given country.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors thank Science and Engineering Research Board and the Department of Science and Technology, Government of India as well as Jamsetji Tata Trust for their continued support.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The article focuses on the statistical analysis of the progression of the COVID-19 pandemic and the correlation between the infection and mortality with the help of simple scaling behavior. In view of that, the given manuscript does not seek any IRB approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the data related to this study are available from the corresponding author upon reasonable request.

  • Abbreviations

    Period
    The total period investigated for any given country
    Mbound
    Lowest bound on the %mortality per detected case as on the last date of analysis, defined as the total number of death divided by the total number of cases on the last date of the analysis period
    Nseg
    Number of segments required for the analysis of this country
    Start date
    The first date included in the analysis of that segment
    End date
    The last date included in the analysis of that segment
    S
    Shift required for the best fit
    F
    Factor required for the best fit
    M
    Mortality rate in %, defined as (100/F)
    Ninfections
    Total number of infections in the specified period between the start and end dates
    Ntests
    Total number of tests in the specified period between the start and end dates
    %Positive cases
    Number of infections detected per hundred tests carried out in the specified period between the start and end dates
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 14, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    A comparative study of infection and mortality in COVID-19 across countries: A scaling analysis
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    A comparative study of infection and mortality in COVID-19 across countries: A scaling analysis
    Ranjan Das, Akmal Hossain, Sayak Mandal, Debasmita Pariari, Rohit Kumar Rohj, Swapnil Shukla, Rahul Mahavir Varma, D. D. Sarma
    medRxiv 2020.10.13.20212175; doi: https://doi.org/10.1101/2020.10.13.20212175
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    A comparative study of infection and mortality in COVID-19 across countries: A scaling analysis
    Ranjan Das, Akmal Hossain, Sayak Mandal, Debasmita Pariari, Rohit Kumar Rohj, Swapnil Shukla, Rahul Mahavir Varma, D. D. Sarma
    medRxiv 2020.10.13.20212175; doi: https://doi.org/10.1101/2020.10.13.20212175

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (166)
    • Anesthesia (49)
    • Cardiovascular Medicine (448)
    • Dentistry and Oral Medicine (80)
    • Dermatology (55)
    • Emergency Medicine (157)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
    • Epidemiology (5206)
    • Forensic Medicine (3)
    • Gastroenterology (194)
    • Genetic and Genomic Medicine (747)
    • Geriatric Medicine (76)
    • Health Economics (212)
    • Health Informatics (691)
    • Health Policy (350)
    • Health Systems and Quality Improvement (221)
    • Hematology (98)
    • HIV/AIDS (161)
    • Infectious Diseases (except HIV/AIDS) (5798)
    • Intensive Care and Critical Care Medicine (355)
    • Medical Education (101)
    • Medical Ethics (25)
    • Nephrology (80)
    • Neurology (754)
    • Nursing (43)
    • Nutrition (129)
    • Obstetrics and Gynecology (141)
    • Occupational and Environmental Health (230)
    • Oncology (473)
    • Ophthalmology (149)
    • Orthopedics (38)
    • Otolaryngology (93)
    • Pain Medicine (39)
    • Palliative Medicine (19)
    • Pathology (138)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (136)
    • Primary Care Research (96)
    • Psychiatry and Clinical Psychology (851)
    • Public and Global Health (1987)
    • Radiology and Imaging (342)
    • Rehabilitation Medicine and Physical Therapy (155)
    • Respiratory Medicine (282)
    • Rheumatology (93)
    • Sexual and Reproductive Health (72)
    • Sports Medicine (74)
    • Surgery (107)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)